Stay updated with breaking news from Samit Mehta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The English-language Greek City Times, quoting unnamed sources, said during talks between Prime Minister Modi and his Greek counterpart Kyriakos Mitsotakis the Indian leader 'expressed the country's interest in acquiring ports in Greece'
A company led by Samit Mehta, executive director at drugmaker Emcure Pharma, has bought an online nutrition and sports supplement brand, two people aware of ......
Gennova Biopharmaceuticals' mRNA Covid-19 booster vaccine, 'Gemcovac Om', has received emergency use authorisation from the office of the Drugs Controller General of India for the Omicron variant. The vaccine is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant and has demonstrated robust immune responses in phase 3 clinical trials. It is stable at two to eight degrees Centigrade and has been developed using Gennova's indigenous platform technology, supported under 'Mission Covid Suraksha'.
According to Gennova, GEMCOVAC-OM is the first booster COVID-19 vaccine developed in India against the highly transmissible Omicron variant TheHealthSite.com
Get latest articles and stories on India at LatestLY. Gennova Biopharmaceuticals Ltd on Wednesday said it is ready with 70 lakh dosages of its Gemcovac-19 vaccine, the first indigenously developed mRNA vaccine against COVID-19 to be approved for restricted emergency use in adults. India News | Gennova Biopharmaceuticals Ready with 70 Lakh Gemcovac-19 Vaccine Dosages.